Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives

Hyperlipidemia characterized by abnormal deposition of cholesterol in arteries can cause atherosclerosis and coronary artery occlusion, leading to atherosclerotic coronary heart disease. The body prevents atherosclerosis by reverse cholesterol transport to mobilize and excrete cholesterol and other lipids. Apolipoprotein A1, the major component of high-density lipoprotein, plays a key role in reverse cholesterol transport. Here, we reviewed the role of apolipoprotein A1-targeting molecules in antiatherosclerosis therapy, in particular ATP-binding cassette transporter A1, lecithin-cholesterol acyltransferase, and scavenger receptor class B type 1.

HDL Is Not Dead Yet

High-density lipoprotein cholesterol (HDL-C) levels are inversely correlated with coronary heart disease (CHD) in multiple epidemiological studies, but whether HDL is causal or merely associated with CHD is unclear. Recent trials for HDL-raising drugs were either not effective in reducing CHD events or, if beneficial in reducing CHD events, were not conclusive as the findings could be attributed to the drugs’ LDL-reducing activity. Furthermore, the first large Mendelian randomization study did not causally relate HDL-C levels to decreased CHD. Thus, the hypothesis that HDL is protective against CHD has been rightfully challenged. However, subsequent Mendelian randomization studies found HDL characteristics that are causally related to decreased CHD. Many aspects of HDL structure and function, especially in reverse cholesterol transport, may be better indicators of HDL’s protective activity than simply measuring HDL-C. Cholesterol efflux capacity is associated with lower levels of prevalent and incident CHD, even after adjustment for HDL-C and apolipoprotein A-1 levels. Also, subjects with very high levels of HDL-C, including those with rare mutations that disrupt hepatic HDL uptake and reverse cholesterol transport, may be at higher risk for CHD than those with moderate levels. We describe here several cell-based and cell-free in vitro assays of HDL structure and function that may be used in clinical studies to determine which of HDL’s functions are best associated with protection against CHD. We conclude that the HDL hypothesis may need revision based on studies of HDL structure and function, but that the HDL hypothesis is not dead yet.

Effectiveness of Yoga, Fast of Dawood, Green Tea and Apple Juice as Suppressors of PPAR-γ, C/EBP-α, and SREBP-c for Management of Obesity on Adolescents

Obesity is a condition that can increase the risk of some diseases such as reduced brain capacity, dyspnea, skin irritation, hypertension, and diabetes. Proper treatment is needed to overcome the problems of obesity. The objective of this study was to investigate the effectiveness of Yoga, fast of Dawood, Green Tea, and Apple juice to suppressor PPAR-γ gene activity, C / EBPα, and SREBP-c to manage obesity in adolescents. The method used in this study was a literature review from journal publications through the database ScienceDirect, PUBMED, and google scholar, and the criteria were Indonesian and English with a range of publication years 2014-2019. Nine main articles were used as references in this study. These articles proved that yoga therapy could maintain the balance and health of the physical, emotional, and spiritual dimensions, and Fast of Dawood can limit the amount of calorie intake at a particular time. Moreover, by consuming green tea as a source of polyphenol derivatives and apples with high of flavanol, anthocyanidin, dihydrochalcones, and hydroxycinnamic acid could decrease adolescents' body weight. Yoga and Fast of Dawood exercise can reduce adipogenesis and induce reverse cholesterol transport, cellular cholesterol released, reduced pro-inflammatory cytokines dan decreased the incidence of obesity.